Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis

참고문헌 (10)

1. Walsh A, "Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity", Gastrointest Endosc Clin N Am, 24, pp.367~378 (2014)[DOI]
2. Kim JH, "Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission", Scand J Gastroenterol, 51, pp.1069~1074 (2016)[DOI]
3. Peyrin-Biroulet L, "Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial", Gut, 63, pp.88~95 (2014)[DOI]
4. Sakiko Hiraoka, "Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis", Gut and Liver, 12(2), pp.142~148 (2018), 거트앤리버 소화기연관학회협의회
5. Ma C, "Noninvasive fecal immunochemical testing and fecal calprotectin predict mucosal healing in inflammatory bowel disease: a prospective cohort study", Inflamm Bowel Dis, 23, pp.1643~1649 (2017)[DOI]
6. Ryu DG, "Assessment of disease activity by fecal immunochemical test in ulcerative colitis", World J Gastroenterol, 22, pp.10617~10624 (2016)[DOI]
7. Mooiweer E, "Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission", J Crohns Colitis, 9, pp.50~55 (2015)[DOI]
8. Molander P, "Outcome after discontinuation of TNFalpha-blocking therapy in patients with inflammatory bowel disease in deep remission", Inflamm Bowel Dis, 20, pp.1021~1028 (2014)
9. Lasson A, "The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis", J Crohns Colitis, 9, pp.26~32 (2015)
10. 장희원, "Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease", Intestinal research, 14(4), pp.305~313 (2016), 대한장연구학회

관련 논문AI추천